[et_pb_section fb_built=”1″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”3_5,2_5″ _builder_version=”4.27.5″ _module_preset=”default” custom_padding=”||3px|||” global_colors_info=”{}”][et_pb_column type=”3_5″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/medconcap.com\/wp-content\/uploads\/2025\/08\/Flyer-Titelseite-ZWM-MCC.jpg” alt=”Partnership for Progress: ZWM-MedConCap” title_text=”ZWM-MCC Key Visual” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”2_5″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
Akademie-ZWM AG and MedConCap GmbH are combining their expertise.<\/p>\n
Our cooperation has the common goal of shaping a new phase of clinical research and product development \u2013 with the aim of translating innovations into practice in a safe, effective and sustainable manner.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” custom_margin=”-12px|||||” global_colors_info=”{}”]<\/p>\n
This partnership provides new impetus for wound care and, through targeted support in data generation, enables greater safety and smoother approval procedures in medicine.<\/p>\n
In memory of our late colleague Dr Thomas Eberlein, we are continuing to pursue his vision of a networked and practice-oriented study landscape. Our common goal is to link existing structures in order to strengthen synergies in a targeted manner.<\/strong> <\/p>\n The requirements for clinical data under the MDR have increased significantly in recent years \u2013 for many manufacturers, this means growing pressure, complex processes and an increasing need for sound clinical expertise. This is precisely where our new partnership comes in.<\/a><\/p>\n Are you planning a clinical trial or require assistance with MDR approval?
Then we look forward to hearing from you!<\/a><\/p>\n